were retrieved from the MEDLINE database using the key word 'total wrist arthroplasty'. In most studies, total wrist arthroplasty achieved improvement in pain and function over time. In a meta-analysis, the revision rate was 17% for third-generation implants. The survival rate was 92% for fourth-generation implants at 4 years. Complication rates ranged from 0% to 100% for third-generation implants and from 6% to 47% for fourth-generation implants. Results of total wrist arthroplasty vary greatly; longer-term studies are needed to determine its cost-effectiveness.
motion and provides functional benefits over wrist arthrodesis. 1 The first-generation implants use a Silastic spacer, with encouraging results for wrists with rheumatoid arthritis (RA), post-traumatic arthritis, and osteoarthritis, 2 but they are associated with osteolysis, subsidence, and implant fractures after 10 years. 3, 4 The second-generation implants use a ball-and-socket or hemispherical design, 3 but the revision rate for the MWP III total wrist prosthesis (Zimmer, Warsaw [IN] , USA) [ Fig.] is high owing to mechanical and soft tissue problems. 5 The thirdgeneration implants such as tri-spherical implants, Biax total wrist prosthesis (DePuy Orthopaedics, Warsaw [IN] , USA) [ Fig.] , and the Universal total wrist implant (Kinetikos Medical, Carlsbad [CA], USA) have higher success rates but are also associated with similar complications. 3 The fourth-generation implants are mainly uncemented and have porous surfaces to enable osteointegration. 3 The Universal 2 total wrist implant system (Integra LifeSciences, Plainsboro [NJ], USA) [ Fig.] and the ReMotion total wrist system (Small Bone Innovations, Morrisville [PA], USA) have porous titanium-coated cobalt chrome components and ultra-high-molecular-weight polyethylene (UHMWPE) articular interfaces to provide better range of motion and reduce torque. 3 TWA enables long-term pain relief and improves overall function, 6 but most studies include small cohorts and poor evidence, and the procedure is associated with complications such as intraoperative fractures, tendon lacerations, wound problems, extensor tendon adhesions, wrist stiffness, wrist imbalance, distal radioulnar joint problems, prosthetic instability, implant loosening, and infection. 7 The revision rate for TWA is high, and thus the cost-effectiveness of TWA over wrist arthrodesis is questionable. In a meta-analysis of 38 studies (involving 1363 patients) that compared TWA with arthrodesis, widespread TWA for wrists with RA is not cost-effective. 7 The present study reviewed the literature on TWA published between January 2003 and April 2013.
REVIEW
The MEDLINE database was searched using the key word 'total wrist arthroplasty'; 18 English-language studies (5 from the United States and 13 from Europe) published between January 2003 and April 2013 were included (Table) . [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Review articles, case reports, surgical techniques, and studies focusing on other operative treatments (wrist arthrodesis, silicone implant arthroplasty, interposition arthroplasty, or proximal row carpectomy) were excluded. The types of studies were retrospective (n=9), pre/post treatment (n=4), prospective (n=2), case series (n=1), registry (n=1), and meta-analysis (n=1). More than 2230 wrists were included, and most involved women. Patient ages ranged from 48 to 64 years. The most common indication was RA, followed by post-traumatic arthritis and osteoarthritis. Follow-up periods ranged from 20 months to at least 9 years. Data reviewed included complications, pain relief, survivorship, patient satisfaction, range of motion, clinical wrist scores, radiological outcome, and reasons for and time to revision. Cost-effectiveness of TWA versus wrist arthrodesis was discussed.
CLINICAL OUTCOMES
14 of the studies reported pain relief, 6, [8] [9] [10] [11] [12] [13] 15, 17, [19] [20] [21] [22] [23] but only 8 used validated scales, and the rest used ordinal scales, severity, and/or frequency to measure pain. Using the visual analogue scale (VAS) for pain, 2 studies reported improvement in the mean score from 8 to 2 (p<0.05) 9 and from 67 to 27 (p<0.001), 23 but one study reported no significant improvement. 22 Using the patient-rated wrist evaluation (PRWE) questionnaire, one study reported improvement in the mean pain scores from 43.0 to 18.2 (p<0.001), 12 and another reported just a mean postoperative score of 11 (standard deviation, 10). 13 One study used the pain component of the Hospital for Special Surgery system and reported a mean postoperative score of 0.4 out of 10. 11 One study reported improvements in the Meuli system score and the VAS score. 8 Another reported marked improvement in patients' pain ratings of the Meuli system. 19 The Meuli system evaluates both subjective (patient satisfaction, pain, and function) and objective (range of motion, grip strength, and radiographic findings) parameters; scores of 11 and 12 are considered excellent, 9 and 10 good, 7 and 8 fair, and ≤6 poor. Wrist function is determined by the range of motion (i.e. extension, flexion, ulnar deviation, radial deviation, pronation, and supination) and grip strength, based on several wrist scoring systems. 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [19] [20] [21] [22] [23] Eight studies used the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire or its shortened version. 9, 12, [14] [15] [16] [17] 22, 23 The DASH questionnaire consists of 30 items related to activities of daily living and symptoms. Scores range from 0 (perfect) to 100. Using the DASH score, one study reported an improvement from 55.1 to 44.8 (p<0.004), 12 and another reported 48% improvement (p<0.001). 15 One study reported improvements in postoperative DASH scores, but preoperative scores were not available. 11 In 2 studies using the shortened version with 11-items, 22, 23 only one reported an improvement from 58 to 42 (p<0.001). 23 Two studies used the PRWE questionnaire, 12, 13 but only one reported improvement of function score from 38.4 to 17.6 (p<0.001) and total score from 81.4 to 35.8 (p<0.001). 12 Two studies reported improvements in the Mueli system score. 8, 19 One study reported improvements in the Hospital for Special Surgery score and Wrightington activities of daily living score. 11 Overall, function improves over time after TWA. Many outcome measures for the wrist overlap those for the hand. The wrist joint works as a unit with the forearm and thus assessing wrist function is complex. Most studies concentrated on movement or strength; only a few have used a wrist scoring system that includes activities of daily living. These tools have not been systematically tested in terms of its psychometric properties (reliability, responsiveness, and validity) in TWA patients, thus making it difficult to compare results across studies. Six studies measured patient satisfaction and all reported a high degree of satisfaction. 11, 13, 15, 16, 19, 22 One reason for dissatisfaction was multiple dislocations. 15 
SURVIVAL
Failure rates for TWA depend on implant design and fixation methods. In a retrospective study of the third-generation, biaxial, cemented, long-stem implant, no failure was reported after 73.9 months. 21 In a retrospective study of a biaxial wrist prosthesis for 32 wrists, the mean cumulative survival after 87 months was 81% (95% confidence interval [CI], 64-91); there were 4 early revisions (range, 8-22 months) and 3 late revisions (range, 59-71 months), mostly for radiographic loosening. 15 In a retrospective study of 40 uncemented APH implants (Implant-Service Vertreibs-GmbH, Hamburg, Germany), the failure rate was 100% at 52 months mostly because of loosening. 20 The original Universal prosthesis also had poor results. In a prospective series of 19 wrists with a mean follow-up of 7.3 years, 9 (45%) wrists required revision surgery for loosening of the carpal component after a mean of 5.5 (range, 2.7-9.3) years. 14 One wrist required wrist arthrodesis owing to recurrent wrist instability, whereas 2 wrists had carpal component subsidence. 14 The implant survival rates at 5 and 7 years were 75% and 60%, respectively. 14 In a meta-analysis, the revision rate for both second-and third-generation implants was 21%, and for third-generation implants alone was 17%; 5.4% and 6.0% of respective implants were removed with or without wrist arthrodesis. 7 According to the Norwegian Arthroplasty Register, the overall 5and 10-year survival rates for the 3 third-generation implants of Biax, Gibbons (Swemac, Linkoping, Sweden), and Elos (Elos Medtech, Gorlose, Denmark) were 78% (95% CI, 70-85) and 71% (95% CI, 59-80), respectively. 18 The individual survival rates were 85% (95% CI, 78-93) at 5 years for Biax, 77% (95% CI, 30-90) at 4 years for Gibbons, and 57% (95% CI, 33-81) at 5 years for Elos. 18 The fourth-generation Universal 2 prosthesis achieves excellent mid-term survival. 6, 12, 13 In a prospective series of 21 TWAs using the Universal 2 prosthesis, no dislocation or instability was reported after 4.8 years, 12 although a few cases of carpal implant loosening were reported after 5 years, 6 whereas osteolysis was noted around the screw tip (but no loosening) at one year. 13 Other fourthgeneration implants such as the Maestro (Biomet, Warsaw [IN], USA) and ReMotion total wrist system also reported low failure rates. One prospective series of the ReMotion implant reported a 0% failure rate at 12 months for 20 wrists. 8 In a multicentre series from Europe involving 215 wrists, implant survival after a mean of 4 years was similar between RA and non-RA patients (96% vs. 92%); implant loosening was the most common cause of revision. 22 One study using the ReMotion implant reported an implant survival of 0.9 at 5 to 9 years; the main cause of revision was loosening. 23 Implant loosening more commonly occurred in the carpal components fixed into the metacarpal shafts. 24 Synovitis, poor bone stock, and use of the upper extremities for ambulation contribute to loosening. 24 Cement is often required in fixation because of the loss of bone stock. 3 Wrist arthrodesis is required for unsalvageable wrists with a complicated course. 3
COMPLICATIONS
The complication rates of TWA can be up to 30% 7 and range from 0% 21 to 100% 20 for the third-generation implants to 6% 22 to 47% 12 for the fourth-generation implants. In a meta-analysis, the complication rate was 21% for the third-generation implants. 7 One study with a 100% failure rate was excluded from the analysis, as it was considered to be an outlier. 20 Wound-healing problems are common in RA patients and those with delicate skin conditions. Risk RA group: Meuli score was excellent in 7, good in 5, poor in one; grip strength improved from 7 to 11 kg; 2 had radiographic loosening (at 12 and 18 months). Non-RA group: Meuli score was excellent in 2, good in 2, fair in 2, poor in one; grip strength improved from 12 to 14 kg 5.5
Flexion arc=68º, extension=26º±14º, flexion=42º±10º; PRWE improved from 24 to 100; 10 very satisfied, 10 satisfied; 2 wound complications, one ulnar subsidence; 18 wrists had no radiolucency or loosening 7.3 DASH improved from 62 to 40, flexion-extension arc from 48º to 62º; 9 (45%) wrists had revision for carpal loosening; 5-year survival of 75% 7.6
Excellent pain relief and satisfaction; total ROM of 125º; grip strength of 31 kg; no luxation, fracture, or failure; 2 distal screw loosenings, one early and one late inflammation 3.8
Overall 5-year survival of 78% (95% CI, 70-85) and 10-year survival of 71% (95% CI, 59-80); respectively for Biax, Gibbon, and Elos, the 5-year survival rates were 85% (95% CI, 78-93), 77% (95% CI, 30-90), and 57% (95% CI, 33-81) 3.8 Improvement in dorsiflexion from 21º to 29º, volar flexion from 30º to 38º, radial deviation from 5º to 7º, ulnar deviation from 12º to 17º; DASH from 91 to 65; pain score; one carpal loosening and one dislocation 4.5 TWA had higher rates of complication (30% vs. 17%), major complications (25% vs. 13%), and revision/ reoperation (21% vs. 15%) than arthrodesis; complication rate for 3rd-generation implants was 21% 2.1 HSS good to excellent in 69%, moderate in 19%, and poor in 12%; VAS for pain was 0.4/10; 63% improvement in Wrightington ADL; 3-fold increase in ROM; 4 early dislocations (3 within 1st year) 1.7 Improvement in ROM (p<0.05); pain-free at rest (n=20) and with movement (n=22); radiographic loosening in 5 wrists; 4 revisions using iliac crest bone grafts 3.9
Meuli scores excellent in 17, good in 6, poor in 4; 84% improved in ROM and grip strength; 4 complications; no imbalance or dislocation; 4-year survival of 85% 4.4 2 infections, 3 implant failures, 2 migrations, 33 loosenings/dislocations; 39 wrists underwent revision for severe titanium wear 6.1 Improvement in radial deviation from 5º to 9º (p=0.001), grip strength from 5.6 to 9.8 kg (p=0.001); 73.9-month survival of 100%; 4 with radiographic lucency, 2 with intra-operative metacarpal fractures factors include inadequate nutrition, uncontrolled diabetes mellitus, steroids, chronic illness, and smoking. Short-term wound complications include haematoma, wound dehiscence, and necrosis. These have been reported for the Universal 13 and Universal 2 14 implants.
Other complications include infection, extensor pollicis longus rupture requiring a tendon transfer, metallosis, and restricted range of motion requiring manipulation. 6, 8, 9, 12, 13, 16, 17, 21, 22 Intra-operative fractures and dislocations have also been reported. 14, 15, 20, 21 For radial fractures, circumferential cerclage wires are used to reapproximate and reinforce the shaft and metaphysis, along with bone grafts in the radial canal if required. 24 For carpal fractures, the defect is augmented with bone grafts and longer screws. 24 In a meta-analysis, the complication rate was 30% for TWA, compared with 17% for arthrodesis. 7 The rate of major complications was higher for TWA than for arthrodesis (25% vs. 13%), whereas the major complication rate for third-generation implants was 21%. 7
RADIOGRAPHIC OUTCOME
Radiographs are used to assess signs of loosening, dislocation, fracture, and placement. Radiographic stages of RA can be classified using the Simmen system 14 and the Larsen classification. 15 For the former, type I is characterised by spontaneous ankylosis of the intercarpal joints with or without radiocarpal fusion; type II is characterised by moderate articular surface destruction with associated subchondral sclerosis and occasional osteophytes, but no evidence of destabilisation; and type III is characterised by carpal collapse, ulnar translocation of the carpus, and osseous destruction with and without subluxations. 14 For the latter, stage 0 is considered normal; stage I shows slight changes such as periarticular soft tissue swelling and a slight decrease in joint space width; stage II shows distinct early changes such as erosion and an obvious decrease in joint space width; stage III shows moderate joint destruction with erosion and advanced narrowing of the joint space; stage IV shows severe joint destruction with erosion and subtotal collapse of the joint space; and stage V shows mutilating changes with total collapse of the joint space. 15 One study reported 7 excellent and 5 good results in the RA group and 2 excellent and 2 good results in the non-RA group, using the Meuli criteria, in which centering of implants with no signs of loosening gets 2 points, whereas wrong placement of the implant or loosening or a fracture gets 0 points. 8 One study used a third-generation implant and reported excellent Meuli score in 17 wrists, good in 6, fair in one, and poor in 4. 19 One study reported 10 (63%) wrists showing no signs of radiolucency at a mean follow-up of 25 months, based on the Mayo zones of radiographic lucency. 11 One study used the Cobb and Beckenbaugh technique to evaluate radiolucent lines around the implants, subsidence and migration of the metacarpal implant, and erosion of the tip of the implant through the cortex of the third metacarpal, 15 in which the metacarpal component is divided into 6 zones and the radial component into 5 zones. A radiolucent line of ≥2 mm is defined as radiographic loosening. The reproducibility of the radiographic measurements was acceptable for the third metacarpal, because the 95% prediction limits were within 5 mm (of subsidence) and 10º (of angular migration). 15 22 implants had radiographic loosening, 5 had a breakout of the third metacarpal cortex (2 intra-operatively), 15 had subsidence of ≥5 mm, 7 had angular migration of ≥10º, and 12 had at least one radiolucent line of ≥2 mm in at least one zone. 15 One study reported 4 (23%) of 17 wrists showing radiographic evidence of lucency without clinical loosening; all involved the distal component. 21 Of the 4 patients, one had lucencies in zones 2 and 3 at 7 years, 2 had isolated lucencies in zone 3 (one each at 5 and 6 years), and one had lucencies in zones 1 and 5 at 4 years; all lucencies occurred in the bone-cement interface. 21 
discussion
Most studies have reported improvement in function and pain after TWA. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Nonetheless, the survival rate for third-generation implants at 10 years is 78%, whereas that for fourth-generation implants in the medium term is ≥90%. Carpal component loosening remains the most common mode of failure, despite design improvements with porous, titaniumcoated cobalt chrome components to promote osteointegration and UHMWPE articular interface to reduce torque. Complication rates for the fourthgeneration implants range from 6% to 47%. Although TWA improves function and reduces pain, this does not translate to decreased complication rates.
In addition to the meta-analysis for second-and third-generation implants, 7 this review added 8 new studies of fourth-generation implants, 6, 8, 9, 12, 13, 16, 22, 23 3 new studies of third-generation implants, 14, 15, 17 and one long-term registry study. 18 TWA tends to fail earlier than hip or knee arthroplasties, but TWA has better short-term outcome. 25 The ideal candidates for TWA are frail, low-demand patients with RA or osteoarthritis seeking pain relief and moderate wrist motion. 24 Patients with better soft tissue envelop and bone stock achieve better outcomes, so this should be one of the selection criteria.
Both patients and physicians prefer surgical over non-surgical management for wrists with RA. The incremental cost per additional quality-adjusted life-years (QALY) gained for TWA over non-surgical management was $2281 and that over total wrist arthrodesis was $2328, which is substantially less than the national standard of $50 000/QALY (or more recent estimate of $100 000/QALY) deemed acceptable for adoption. 26 Therefore, both TWA and total wrist arthrodesis are very cost-effective. 26 disclosure No conflicts of interest were declared by the authors.
